Advancing treatments for rare diseases together

  • Our focus

    Watch our Founder talk about EspeRare
    Click here

  • Addressing genetic rare diseases

    We focus on developing treatments for debilitating rare diseases with high unmet medical needs
    Read more

  • Patient-centric approach

    EspeRare fully engages the patient community at each step of the drug development process
    Read more

Our mission and vision

We aim to give children and their families, affected by the orphan diseases, a fair access to life-changing therapies and a new hope for the future.

Our model

Hand-in-hand with patients, EspeRare rescues and repositions therapies in rare diseases, thus accelerating the development of accessible treatments for these underserved patients.

R&D programmes

EspeRare is building a diversified portfolio of programmes with strong therapeutic potential. Today, our programmes include genetic diseases affecting muscle, heart and skin.

Recent news

14Feb

EspeRare involved in the RDI-Lancet Commission on Rare Diseases

Sharon Terry, EspeRare ’s President...
28Oct

EspeRare at the iFeTIS 2024 Congress, USA

EspeRare is participating in the 8th iFeTIS Annual Meeting, being represented by Agnes Jaulent, PhD, and Sebastien Mazzuri, MD. The event taking...

Testimonials

  • It is time to renovate and accelerate the discovery and development of drugs for rare diseases. Esperare is an essential player in the innovative, collaborative system that will be created to make a difference in this world.
    Sharon Terry
    President of EspeRare and CEO of Genetic Alliance
  • As a nonprofit organisation, our priorities are not determined by the size of a market, they are solely defined by the medical needs and great science. Above all, we strive to apply our patient-centric model and pharma know-how to advance new treatments for underserved patients.
    Caroline Kant
    EspeRare's Founder and Executive Director
  • For me it is a privilege to represent Merck Serono on the Board of EspeRare, I firmly believe that this exciting new Foundation can make a real difference to the lives of patients with Duchenne Muscular Dystrophy and other rare diseases.
    Ewen Sedman
    Board member
  • Fostering access to health for patients that are the most in need is what this foundation is about, and is what I am about.
    Beatrice Greco
    EspeRare's Founder and Member of the Board
  • Duchenne is a heartbreaking disease. Children like Laurent, my cousin, affected with this disease are bright and engaged but as they grow up, they inexorably get weaker and experience the loss of the few abilities they had acquired. I have in my genes the eagerness to find treatments for this disease and I am committed to give them the strength to fight their disease.
    Florence Porte-Thomé
    EspeRare's Founder and R&D Director

We use cookies on this site to enhance your user experience

Please check our Disclaimer and Privacy Notice